Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 121 Neoplasm Metastasis 12 Prostate Cancer Metastatic 4 Oligometastatic Prostate Cancer 3 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 3 Metastatic Hormone-sensitive Prostate Cancer 3 Adenocarcinoma 3 Radiation Injuries 2 Prostatic Diseases 2 Prostate CA 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Metastatic Castration-resistant Prostate Cancer 2 Urologic Diseases 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage IV Prostate Adenocarcinoma AJCC v7 1 Stage I Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Adenocarcinoma 1 PSA Level Greater Than 0.03 1 Oligorecurrent and Oligoprogressive Prostate Cancer Patients 1 Non-metastatic, Hormone naïve Prostate Cancer 1 Neoplasm Recurrence, Local 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Hormone-Sensitive Prostate Cance 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1

Interventions

Trastuzumab 628 Paclitaxel 577 Cyclophosphamide 555 Docetaxel 485 Capecitabine 402 Letrozole 376 Fulvestrant 327 Doxorubicin 294 Carboplatin 279 Tamoxifen 275 Anastrozole 243 exemestane 228 Radiotherapy 218 Epirubicin 211 Bevacizumab 196 palbociclib 189 pertuzumab 186 Vinorelbine 167 Lapatinib 167 Gemcitabine 166 pembrolizumab 162 Surveys and Questionnaires 139 Exercise 136 Magnetic Resonance Spectroscopy 123 Fluorouracil 119 Blood Specimen Collection 118 eribulin 117 Albumin-Bound Paclitaxel 117 Drug Therapy 111 130-nm albumin-bound paclitaxel 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Androgen Antagonists × Clear all

NCT07340541 2026-05-20

EVOLVE-BDT

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡